DAVION HEALTHCARE PLC CONFIRMS EXPECTED NASDAQ TRADING DATE AND ANNOUNCES NEW EXECUTIVE LEADERSHIP AND OPERATING STRUCTURE

Jack Kaye, current Chief Executive Officer and incoming Chairman of Davion Healthcare Plc

“The expected commencement of trading on Nasdaq is a major milestone for Davion and comes during Breast Cancer Awareness Month as we advance the commercialisation of our flagship BreastCheck technology.”

Jack Kaye, current Chief Executive Officer and incoming Chairman of Davion Healthcare Plc

“Alongside our broader portfolio of proprietary health monitoring technologies, we intend to pursue acquisitions that add revenues, earnings and commercial capabilities to the Group.”

Jack Kaye, current Chief Executive Officer and incoming Chairman of Davion Healthcare Plc

“The establishment of the Operational Directorate, led by Glenn and supported by Jeremy and the wider executive team, provides the management structure to deliver our growth plans. I look forward to working with them as we build Davion into a substantial international healthcare company.”

Glenn Williams, incoming Chief Executive Officer of Davion Healthcare Plc

“Davion has developed a strong portfolio of proprietary healthcare technologies with significant commercial potential and has established a platform from which we can pursue both organic and acquisition-led growth.”

Glenn Williams, incoming Chief Executive Officer of Davion Healthcare Plc

“My focus will be on translating that potential into commercial performance: bringing products to market, expanding our distribution capabilities, strengthening the business operationally and identifying complementary acquisitions capable of accelerating the Group's development.”

Glenn Williams, incoming Chief Executive Officer of Davion Healthcare Plc

“I am delighted to be joining Davion at such an important point in its development and look forward to working with Jack, Jeremy, the Board and the wider team.”

Jeremy North, incoming Chief Operating Officer of Davion Healthcare Plc

“Davion has a clear opportunity to grow both organically and through acquisition. As Chief Operating Officer and a member of the Operational Directorate, my focus will be on execution: developing the Group's operating capabilities, supporting the evaluation and completion of acquisition opportunities and ensuring that acquired businesses and technologies are integrated effectively.”